Form EFFECT Keros Therapeutics, Inc.
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | September 16, 2026 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Hello Flores, Leading Komodo Yacht Charter Platform, Passes 12,500 Travelers Across Komodo Liveaboard and Charter Fleet
- ULTRA-RARE MCA CENTENAIRE, MONACO’S FIRST SUPERCAR, OFFERED AT BROAD ARROW’S 2026 ZOUTE CONCOURS AUCTION
- The 140th Canton Fair to Open on Oct. 15 with Over 220,000 Pre-registered Overseas Buyers
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share